TP53 and head and neck neoplasms
Open Access
- 24 February 2003
- journal article
- review article
- Published by Hindawi Limited in Human Mutation
- Vol. 21 (3) , 252-257
- https://doi.org/10.1002/humu.10171
Abstract
Head and neck cancer is an important health problem around the world, accounting for approximately 500,000 new cases each year of head and neck squamous cell carcinoma (HNSCC). Carcinogenesis of head and neck results from a dysregulation of cellular proliferation, differentiation, and cell death. The major etiologic agents are tobacco and alcohol consumption and for some cases, human papilloma virus (HPV) infection. All three factors are associated with the disruption of a cellular pathway essential for the maintenance of cellular integrity, the p53 pathway. The objective of this review is to point out the specificity of p53 gene (TP53) alterations in head and neck cancer in relation with chemocarcinogenesis and to discuss whether or not the determination of p53 alterations will be of clinical relevance in the management of head and neck cancer in terms of prognosis and response to treatments. Hum Mutat 21:252–257, 2003.Keywords
This publication has 41 references indexed in Scilit:
- The IARC TP53 database: New online mutation analysis and recommendations to usersHuman Mutation, 2002
- Prognostic significance of p53, bax and bcl-2 gene expression in patients with laryngeal carcinomaEuropean Journal of Surgical Oncology, 2001
- Characteristics of mutations in the p53 gene in oral squamous cell carcinoma associated with betel quid chewing and cigarette smoking in TaiwaneseCarcinogenesis: Integrative Cancer Research, 2001
- Glutathione-associated enzymes in head and neck squamous cell carcinoma and response to cisplatin-based neoadjuvant chemotherapyInternational Journal of Cancer, 2001
- Human Papillomavirus Infection as a Risk Factor for Squamous-Cell Carcinoma of the Head and NeckNew England Journal of Medicine, 2001
- Ki‐67 (MIB1), p53, and Lewis‐X (LeuM1) as Prognostic Factors of Recurrence in T1 and T2 Laryngeal CarcinomaThe Laryngoscope, 2000
- P53 tumor suppressor gene as a clonal marker in head and neck squamous cell carcinoma: P53 mutations in primary tumor and matched lymph node metastasesOral Oncology, 1999
- Analysis of p53 Serum Antibodies in Patients With Head and Neck Squamous Cell CarcinomaJNCI Journal of the National Cancer Institute, 1996
- Surgical pathology of cancer of the oral cavity and oropharynxThe Laryngoscope, 1991
- Estimates of the worldwide frequency of sixteen major cancers in 1980International Journal of Cancer, 1988